1. Home
  2. PAHC vs ASTH Comparison

PAHC vs ASTH Comparison

Compare PAHC & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • ASTH
  • Stock Information
  • Founded
  • PAHC 1946
  • ASTH 1994
  • Country
  • PAHC United States
  • ASTH United States
  • Employees
  • PAHC N/A
  • ASTH N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • ASTH Professional Services
  • Sector
  • PAHC Health Care
  • ASTH Consumer Discretionary
  • Exchange
  • PAHC Nasdaq
  • ASTH Nasdaq
  • Market Cap
  • PAHC 1.2B
  • ASTH 1.3B
  • IPO Year
  • PAHC 2014
  • ASTH N/A
  • Fundamental
  • Price
  • PAHC $38.58
  • ASTH $29.08
  • Analyst Decision
  • PAHC Hold
  • ASTH Strong Buy
  • Analyst Count
  • PAHC 4
  • ASTH 8
  • Target Price
  • PAHC $27.50
  • ASTH $53.29
  • AVG Volume (30 Days)
  • PAHC 391.5K
  • ASTH 333.2K
  • Earning Date
  • PAHC 11-05-2025
  • ASTH 11-06-2025
  • Dividend Yield
  • PAHC 1.25%
  • ASTH N/A
  • EPS Growth
  • PAHC 1895.04
  • ASTH N/A
  • EPS
  • PAHC 1.19
  • ASTH 0.52
  • Revenue
  • PAHC $1,296,215,000.00
  • ASTH $2,419,115,000.00
  • Revenue This Year
  • PAHC $13.56
  • ASTH $60.77
  • Revenue Next Year
  • PAHC $3.06
  • ASTH $26.90
  • P/E Ratio
  • PAHC $32.35
  • ASTH $56.27
  • Revenue Growth
  • PAHC 27.37
  • ASTH 51.97
  • 52 Week Low
  • PAHC $16.16
  • ASTH $21.20
  • 52 Week High
  • PAHC $41.57
  • ASTH $63.20
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 62.46
  • ASTH 49.52
  • Support Level
  • PAHC $38.60
  • ASTH $28.48
  • Resistance Level
  • PAHC $41.57
  • ASTH $30.58
  • Average True Range (ATR)
  • PAHC 1.63
  • ASTH 1.21
  • MACD
  • PAHC -0.17
  • ASTH -0.37
  • Stochastic Oscillator
  • PAHC 61.20
  • ASTH 16.30

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About ASTH Astrana Health Inc. Common Stock

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Share on Social Networks: